Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Innoviva (INVA) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to 32.08%.

  • Innoviva's EBITDA Margin fell 1623.00% to 32.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.79%, marking a year-over-year decrease of 1148.00%. This contributed to the annual value of 2.19% for FY2024, which is 1094.00% down from last year.
  • As of Q3 2025, Innoviva's EBITDA Margin stood at 32.08%, which was down 34.02% from 48.61% recorded in Q2 2025.
  • In the past 5 years, Innoviva's EBITDA Margin ranged from a high of 8,265.41% in Q2 2021 and a low of -1,668.23% during Q1 2025.
  • In the last 3 years, Innoviva's EBITDA Margin had a median value of -430.50% in 2023 and averaged -556.58%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first spiked by 816,941bps in 2021, then slumped by 875,506bps in 2022.
  • Innoviva's EBITDA Margin (Quarterly) stood at -611.53% in 2021, then slumped by 37,116bps to -982.68% in 2022, then surged by 55,219bps to -430.50% in 2023, then slumped by 42,286bps to -853.36% in 2024, then slumped by 1,623bps to 32.08% in 2025.
  • Its last three reported values are 32.08% in Q3 2025, 48.61% for Q2 2025, and -1,668.23% during Q1 2025.